MDDI Online is part of the Informa Markets Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

6 Things You Should Know About the Emerging TMVR Market

Canaccord Genuity's Jason Mills shares these important themes from his deep-dive analysis on the transcathter mitral valve replacement (TMVR) market. Mills notes a multibillion-dollar market opportunity, but the field must overcome several hurdles to realize the full TMVR potential.

The transcatheter mitral valve replacement market is still in its infancy, according to Jason Mills, a medtech analyst at Canaccord Genuity.

MD+DI/Amanda Pedersen

For recent MD+DI coverage on the promising field of transcatheter mitral valve replacement/repair, check out these stories:

Abbott Wins Additional Indication for MitraClip

Cardiovalve Makes Crucial Move in TMVR Market

Abbott Makes Strong Statement in TMVR Space with SUMMIT

LivaNova Looks to Be a Standout Firm in TMVR

Filed Under
500 characters remaining